ABCC7 p.Glu656*
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 12913074
[PubMed]
Aznarez I et al: "Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene."
No.
Sentence
Comment
2
In this study, we have investigated the consequence of two cystic fibrosis (CF) disease-causing mutations, E656X and 2108delA, on the function of a putative exonic splicing enhancer (ESE) in exon 13 of the CFTR gene.
X
ABCC7 p.Glu656* 12913074:2:107
status: NEW4 Using minigene constructs, we have demonstrated that the E656X and 2108delA mutations could indeed cause aberrant splicing in a predicted manner, supporting a role for the putative ESE sequence in pre-mRNA splicing.
X
ABCC7 p.Glu656* 12913074:4:57
status: NEW78 It was noted that two exon 13 mutations, E656X (http:// www.genet.sickkids.on.ca/cftr/) and 2108delA (27), were located within the putative ESE in exon 13 (Fig. 2A).
X
ABCC7 p.Glu656* 12913074:78:41
status: NEW79 The E656X mutation corresponded to a G to T substitution at nucleotide 2098; affecting the first nucleotide of the stretch of purine-rich ESE sequence, whereas 2108delA shortened the ESE sequence by one nucleotide.
X
ABCC7 p.Glu656* 12913074:79:4
status: NEW111 (D) RT-PCR analysis of minigenes carrying the wild-type sequence, WT, and E656X and 2108delA mutations separated in a 2% agarose gel.
X
ABCC7 p.Glu656* 12913074:111:74
status: NEW138 As shown in Figure 4A, co-transfection with the hTra2a-expressing construct could partially suppress the defective splicing caused by the E656X and 2108delA mutations (compare lanes 1 to 2 and 3 to 4, respectively).
X
ABCC7 p.Glu656* 12913074:138:138
status: NEW175 Using a CFTR minigene construct, we have found that two previously reported CFTR mutations, E656X and 2108delA, located in the ESE consensus sequence could actually cause aberrant splicing of exon 13.
X
ABCC7 p.Glu656* 12913074:175:92
status: NEW186 Therefore, our results showing that two nonsense mutations, E656X and E664X, affect the splicing of exon 13 acquire particular importance.
X
ABCC7 p.Glu656* 12913074:186:60
status: NEW196 Minigenes carrying E656X, 2108delA, MTand D648V mutations were transfected alone (noted by the minus sign) or co-transfected with hTra2a (noted by the plus sign).
X
ABCC7 p.Glu656* 12913074:196:19
status: NEW211 Increased expression of hTra2a decreased the aberrant splicing of exon 13 caused by two exonic splicing mutations, E656X and 2108delA.
X
ABCC7 p.Glu656* 12913074:211:115
status: NEW221 The mutations were reported to associate with CF phenotype [D648V (31), E656X (http:// www.genet.sickkids.on.ca/cftr/), 2108delA (27), E664X (33) and T665S (http://www.genet.sickkids.on.ca/cftr/)] or with pulmonary disease [D651N (32)].
X
ABCC7 p.Glu656* 12913074:221:72
status: NEW
PMID: 19318346
[PubMed]
Goubau C et al: "Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis."
No.
Sentence
Comment
60
Table 2 CFTR mutations in the patient subgroups CF-PS CFTR dysfunction CF unlikely Genotype Subjects (n) Genotype Subjects (n) Genotype Subjects (n) F508del*/Not found 12 F508del*/3849+10 kb(C.T){ 11 Not found/Not found 39 Not found/Not found 10 F508del*/R117H{ 7 F508del*/Not found 4 F508del*/3849+10 kb(C.T){ 7 F508del*/Not found 7 IVS8-5T{/Not found 1 F508del*/R347P{ 5 Not found/Not found 5 S1235E/E528E 1 F508del*/R117H{ 4 F508del*/D1152H{ 4 No mutation analysis 1 F508del*/2789+5G.A{ 4 F508del*/IVS8-5T{ 4 Total 46 F508del*/S945L* 3 F508del*/S945L* 2 2789+5G.A{/Not found 3 W1282X*/IVS8-5T{ 2 F508del*/3272-26 A.G{ 2 F508del*/R1070W{ 1 F508del*/A455E{ 2 F508del*/L159S 1 F508del*/711+5G.A 2 F508del*/T1246I 1 F508del*/2789+5G.A 2 F508del*/L165S 1 G542X*/R334W{ 2 W1282X*/D1152H{ 1 F508del*/R334W{ 2 R1162X*/D1152H{ 1 R347P{/Not found 2 R347Hu/D1152H{ 1 F508del*/2116delCTAA 1 R553X*/R117H{ 1 F508del*/IVS8-5T{ 1 3659delC*/R117H{ 1 F508del*/D1152H{ 1 3849+10kb(C.T){/G551R 1 F508del*/711+3A.G 1 R1162X*/3849+10 kb(C.T){ 1 F508del*/L206W{ 1 2789+5G.A{/Not found 1 F508del*/I336K{ 1 G542X*/T854A 1 F508del*/G970D 1 R553X*/Q1463H 1 F508del*/L159S 1 S1235R/R668C 1 F508del*/R751L 1 2789+5G.A{/S977F 1 F508del*/E656X 1 No mutation analysis 1 F508del*/4015delA 1 Total 59 F508del*/Y913S 1 F508del*/L165S 1 F508del*/2143delT 1 G551D*/I336K{ 1 G551D*/3272-26A.G{ 1 G551D*/711+3A.G 1 R553X*/4005+2T.C 1 R553X*/E92K{ 1 G542X*/L206W{ 1 W1282X*/I336K 1 R1162X*/3849+10 kb(C.T){ 1 R1162X*/2789+5G.A{ 1 574delA*/3141del9 1 9890X/I105N 1 R334W{/R1070Q{ 1 3272-26A.G{/4218insT 1 3272-26A.G{/L165S 1 711+3A.G/G1244E 1 R352Q/1812-1G.A 1 F1052V/IVS8-5T{ 1 R74W/D1270N 1 1898-3G.A/1898-3G.A 1 1717-1G.A*/R334W{ 1 3659delC*/Not found 1 394delTT/Not found 1 R1162X*/Not found 1 R553X*/Not found 1 R117H{/Not found 1 G85E*/Not found 1 3849+10k(C.T){/Not found 1 Total 103 *Mutation class I, II or III.
X
ABCC7 p.Glu656* 19318346:60:1211
status: NEW